Page last updated: 2024-09-03
hwa 138 and fibrinogen
hwa 138 has been researched along with fibrinogen in 1 studies
Compound Research Comparison
| Studies (hwa 138) | Trials (hwa 138) | Recent Studies (post-2010) (hwa 138) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 34,477 | 1,707 | 7,083 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bahrami, S; Buurman, WA; Redl, H; Schlag, G | 1 |
Other Studies
1 other study(ies) available for hwa 138 and fibrinogen
| Article | Year |
|---|---|
Influence of the xanthine derivate HWA 138 on endotoxin-related coagulation disturbances: effects in non-sensitized vs D-galactosamine sensitized rats.
Topics: Animals; Antithrombin III; Blood Coagulation Disorders; Blood Glucose; Fibrinogen; Galactosamine; Hematologic Tests; Immunization; In Vitro Techniques; Leukocyte Count; Lipopolysaccharides; Male; Partial Thromboplastin Time; Pentoxifylline; Platelet Count; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1992 |